Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

597 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficient double-flowered gentian plant production using the CRISPR/Cas9 system.
Nishihara M, Hirabuchi A, Goto F, Watanabe A, Yoshida C, Washiashi R, Odashima M, Nemoto K. Nishihara M, et al. Among authors: yoshida c. Plant Biotechnol (Tokyo). 2023 Sep 25;40(3):229-236. doi: 10.5511/plantbiotechnology.23.0424a. Plant Biotechnol (Tokyo). 2023. PMID: 38420567 Free PMC article.
Corrigendum to "Aloe vera and copaiba oleoresin-loaded chitosan films for wound dressings: Microbial permeation, cytotoxicity, and in vivo proof of concept" [Int. J. Pharm. 634 (2023) 122648].
Genesi BP, de Melo Barbosa R, Severino P, Rodas ACD, Yoshida CMP, Mathor MB, Lopes PS, Viseras C, Souto EB, da Silva CF. Genesi BP, et al. Among authors: yoshida cmp. Int J Pharm. 2024 Mar 5;652:123823. doi: 10.1016/j.ijpharm.2024.123823. Epub 2024 Jan 26. Int J Pharm. 2024. PMID: 38278627 No abstract available.
Barriers to Healthcare for Latinx Autistic Children and Adolescents.
Grosvenor LP, Cohen RJ, Gordon NP, Massolo ML, Cerros HJ, Yoshida CK, Ames JL, Croen LA. Grosvenor LP, et al. Among authors: yoshida ck. J Autism Dev Disord. 2024 Jan 17. doi: 10.1007/s10803-023-06229-7. Online ahead of print. J Autism Dev Disord. 2024. PMID: 38231382
Female and preserved platelet count subgroups of myelodysplastic syndrome patients benefit from standard-dose azacitidine.
Ogawa S, Sakamoto T, Matsuoka R, Ishitsuka K, Ogino Y, Sootome A, Makishima K, Yoshida C, Ito Y, Shimizu S, Suyama T, Shinagawa A, Ito T, Obara N, Kusakabe M, Sakata-Yanagimoto M, Miyazaki Y, Nannya Y, Chiba S. Ogawa S, et al. Among authors: yoshida c. Cancer Rep (Hoboken). 2024 Jan;7(1):e1938. doi: 10.1002/cnr2.1938. Epub 2023 Nov 28. Cancer Rep (Hoboken). 2024. PMID: 38014499 Free PMC article.
597 results